Pyxis Oncology, Inc.
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targ…
Biotechnology
US, Cambridge [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Pyxis Oncology, Inc. has no acquisition track records yet.
M&A Deals · History
Pyxis Oncology, Inc. has no acquisition track records yet.